Literature DB >> 21570312

Combined treatment of aggressive central giant cell granuloma in the lower jaw.

Adi Rachmiel1, Omri Emodi, Edmond Sabo, Dror Aizenbud, Micha Peled.   

Abstract

BACKGROUND: The aggressive type lesions of central giant cell granuloma (CGCG) require wide resection that leads to major defects in the jaws. This form of surgical treatment can be particularly disfiguring. A number of alternative non-surgical therapies have been advocated in recent years for the management of the central giant cell granuloma (CGCG). These include calcitonin injections and nasal spray, intralesional steroid injections and subcutaneous interferon injections.
MATERIALS AND METHODS: A large central giant cell granuloma aggressive type lesion in the mandible of a 24-year-old patient was treated successfully by intralesional injection of corticosteroid and nasal spray calcitonin that was followed by curettage with peripheral ostectomy with preservation of the continuity of the mandible and the teeth. At the 5-year clinical and radiological follow up there was no sign of recurrence.
CONCLUSIONS: This combined medical and surgical treatment is advantageous for large aggressive lesions in order to reduce the size of the lesion and thus minimize the need for extensive bone resection and loss of teeth that can result in functional and aesthetic defects.
Copyright © 2011 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570312     DOI: 10.1016/j.jcms.2011.04.002

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  6 in total

1.  Management of central giant cell granuloma of the jaws with intralesional steroid injection and review of the literature.

Authors:  Doğan Dolanmaz; Alparslan Esen; Ahmet Mihmanlı; Kubilay Işık
Journal:  Oral Maxillofac Surg       Date:  2015-10-19

2.  Management of recurrent central giant cell granuloma of mandible using intralesional corticosteroid with long-term follow-up.

Authors:  Kumar Nilesh; Anuj Dadhich; Rahul Patil
Journal:  BMJ Case Rep       Date:  2020-09-14

3.  Intra-Lesional Medicaments for the Management of Intra-Osseous Lesions of Maxilla and Mandible - Systematic Review.

Authors:  Komal Smriti; Evit John; Kalyana-Chakravarthy Pentapati; Srikanth Gadicherla; Manish Bhagania
Journal:  J Int Soc Prev Community Dent       Date:  2020-01-24

4.  Treatment of central giant cell lesions using bisphosphonates with intralesional corticosteroid injections.

Authors:  Newton Guerreiro Júnior da Silva; Aline Semblano Dias Carreira; Erick Nelo Pedreira; Fabrício Mesquita Tuji; Karem López Ortega; João de Jesus Viana Pinheiro
Journal:  Head Face Med       Date:  2012-08-22       Impact factor: 2.151

5.  Giant cell granuloma of the temporal bone in a mixed martial arts fighter.

Authors:  Jennifer Maerki; Nicole D Riddle; Jason Newman; Michael A Husson; John Y K Lee
Journal:  J Neurol Surg Rep       Date:  2012-08-08

6.  Intralesional corticosteroid injections in the treatment of central giant cell lesions of the jaws: a meta-analytic study.

Authors:  Rafael-Lima-Verde Osterne; Phelype-Maia Araújo; Abrahao-Cavalcante-Gomes de Souza-Carvalho; Roberta-Barroso Cavalcante; Eduardo Sant'Ana; Renato-Luiz-Maia Nongueira
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.